{
"id":"mk19_a_np_q094",
"number":94,
"bookId":"np",
"correctAnswer":"C",
"title":"Question 94",
"stimulus":[
{
"type":"p",
"hlId":"b60216",
"children":[
"An 84-year-old woman is evaluated during a follow-up visit for stage G4 chronic kidney disease. Her only symptom is lack of energy. She is independent in her activities of daily living. She has declined renal replacement therapy after attending a dialysis education class. She understands the process and purpose of dialysis and the consequence of non-treatment but prefers non-dialytic therapy. Medical history is also significant for diabetes mellitus, heart failure, hypertension, and stroke. Medications are furosemide, lisinopril, hydralazine, insulin aspart, insulin detemir, nifedipine, metoprolol, and aspirin, 81 mg."
]
},
{
"type":"p",
"hlId":"89f8b5",
"children":[
"On physical examination, blood pressure is 160/72 mm Hg, and pulse rate is 60/min; other vital signs are normal. Cardiac examination reveals an S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
". The remainder of the examination is noncontributory."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"1a4da4",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Calcium, serum",
"children":[
"Calcium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"1c67e8",
"class":"cell text l",
"children":[
"9.4 mg/dL (2.4 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e6438c",
"class":"cell text l",
"children":[
"2.3 mg/dL (203.3 Âµmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"e92687",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Potassium, serum",
"children":[
"Potassium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"fcabe9",
"class":"cell text l",
"children":[
"4.7 mEq/L (4.7 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"a4922e",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Phosphorus, serum",
"children":[
"Phosphorus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"cf51f3",
"class":"cell text l",
"children":[
"4.4 mg/dL (1.4 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"77db81",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Glomerular filtration rate (GFR), urine",
"children":[
"Estimated glomerular filtration rate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"662bd2",
"class":"cell text l",
"children":[
"26 mL/min/1.73 m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" "
]
}
]
}
]
}
]
}
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"cb2b54",
"children":[
"Which of the following is the most appropriate management?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Add a phosphate binder"
}
},
{
"letter":"B",
"text":{
"__html":"Discontinue all medications except insulin"
}
},
{
"letter":"C",
"text":{
"__html":"Intensify hypertension management"
}
},
{
"letter":"D",
"text":{
"__html":"Refer for hospice care"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"04b6c7",
"hvc":true,
"children":[
"The goal of non-dialytic palliative therapy in patients with end-stage kidney disease involves ongoing medical management of medical problems to prolong comfort and functioning."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"c7a9aa",
"children":[
"The most appropriate management is to intensify hypertension management (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
"). Treatment options for patients with end-stage kidney disease (ESKD) include dialysis, transplantation, and the less aggressive option of non-dialytic medical management only. Shared decision-making is vital with these patients. This patient reached an informed decision to pursue non-dialytic medical management. This management is particularly appropriate for older patients with ESKD and comorbid conditions who may gain only minimal, if any, additional lifespan. Non-dialytic medical therapy avoids the burdens of dialysis and is associated with fewer hospitalizations compared with older patients who initiate hemodialysis. The goal of medical management is to prolong the comfort and functioning of a patient's life through ongoing medical management of medical problems. The appropriate intervention for this patient is to intensify her hypertension management, as she has a history of stroke and her blood pressure is 160/72 mm Hg. Blood pressure recommendations differ for older patients, but reduction of systolic blood pressure to <140 mm Hg in patients with stroke is generally supported."
]
},
{
"type":"p",
"hlId":"4dd0a6",
"children":[
"Adding a phosphate binder (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") is not appropriate management, as her serum phosphorus level is in the normal range."
]
},
{
"type":"p",
"hlId":"2d471f",
"children":[
"Discontinuing all medications other than insulin (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") in not compatible with the philosophy of non-dialytic medical management, which includes ongoing medical management of medical problems."
]
},
{
"type":"p",
"hlId":"840bc3",
"children":[
"This patient functions well in her life and has no particular needs that will be met with hospice care. Hospice referral (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") may be indicated in the future as her chronic kidney disease progresses."
]
}
],
"relatedSection":"mk19_a_np_s12_9_1_3",
"objective":{
"__html":"Manage end-stage kidney disease with non-dialytic palliative therapy."
},
"references":[
[
"van Loon IN, Goto NA, Boereboom FTJ, et al. Quality of life after the initiation of dialysis or maximal conservative management in elderly patients: a longitudinal analysis of the Geriatric assessment in OLder patients starting Dialysis (GOLD) study. BMC Nephrol. 2019;20:108. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30922246",
"target":"_blank"
},
"children":[
"PMID: 30922246"
]
},
" doi:10.1186/s12882-019-1268-3"
]
],
"hospitalist":false,
"hvc":true,
"peerComparison":{
"A":27,
"B":1,
"C":52,
"D":21,
"E":0
},
"hlIds":[
"b60216",
"89f8b5",
"a462a3",
"1a4da4",
"1c67e8",
"f461b2",
"e6438c",
"e92687",
"fcabe9",
"a4922e",
"cf51f3",
"77db81",
"662bd2",
"cb2b54",
"04b6c7",
"c7a9aa",
"4dd0a6",
"2d471f",
"840bc3"
]
}